MLYSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Mineralys Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$20.92+0.62 (+3.05%)
Close on Oct 19, 2026
- Market cap
- $1.77B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Mineralys Therapeutics has not reported a dividend
No dividend per share appears in Mineralys Therapeutics's annual filings since fiscal 2021.